Marc Lustig

Marc Lustig

Algemeen Directeur bij PHARMACIELO LTD.

Vermogen: 2 M $ op 31-05-2026

53 jaar
Finance
Process Industries
Health Technology

Profiel

Marc Lustig was the founder of CannaRoyalty Corp., founded in 2015, serving as Executive Chairman & Chief Executive Officer from 2018 to 2020.
Mr. Lustig was the founder of Trichome Financial Corp., founded in 2017, serving as Chairman from 2017 to 2021.
Mr. Lustig is the founder of Cannabis Royalties & Holdings Corp., founded in 2015, serving as Chief Executive Officer & Director from 2015 to 2020.
Mr. Lustig is also the founder of Cedars Cancer Foundation.
Mr. Lustig is Chairman & Chief Executive Officer at PharmaCielo Ltd. since 2023.
Mr. Lustig is Director at Cresco Labs LLC.
Mr. Lustig is Independent Director at Aequus Pharmaceuticals, Inc. since 2021.
Mr. Lustig is Director at Resolve Digital Health, Inc. Mr. Lustig is Director at L5 Capital, Inc. Mr. Lustig is Director at Cresco Labs, Inc. (Arizona) since 2021.
Mr. Lustig is Director at Cresco Labs, Inc. since 2020.
Mr. Lustig was Chairman at META Growth Corp.
from 2018 to 2020.
Mr. Lustig was Chairman at Trichome Financial Corp.
Mr. Lustig was Chairman at Wellfield Technologies, Inc. from 2021 to 2023.
Mr. Lustig was Executive Chairman at IM Cannabis Corp.
from 2019 to 2024.
Mr. Lustig was Director at RF Capital Group, Inc. Mr. Lustig was Independent Director at 22 Capital Corp.
Mr. Lustig was Independent Director at Planet 13 Holdings, Inc. from 2018 to 2019.
Mr. Lustig was Independent Director at BriaCell Therapeutics Corp.
from 2021 to 2024.
Mr. Lustig was Head-Capital Markets at Merck & Co., Inc. Mr. Lustig was Principal at Griffiths McBurney Corp.
Mr. Lustig was Head-Capital Markets at Dundee Capital Markets, Inc. from 2012 to 2014.
Mr. Lustig was Sales Associate at GMP Securities LP.
Mr. Lustig was Vice President at Orion Securities, Inc. Mr. Lustig was Principal at KES 7 Capital, Inc. Mr. Lustig completed graduate and MBAistration degrees at McGill University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
16-03-2026 24.262.580 ( 12,91% ) 2 M $ 31-05-2026
23-02-2026 192.232 ( 0,06% ) 176 277 $ 31-05-2026
21-04-2025 10.198.958 ( 4,92% ) 71 393 $ 31-05-2026
10-12-2024 17.403 ( 0,24% ) 63 347 $ 31-05-2026
24-09-2025 6.916.666 ( 5,21% ) 6 917 $ 31-05-2026
01-08-2025 1.589 ( 99,94% ) 1 457 $ 31-05-2026

Actieve functies van Marc Lustig

BedrijvenFunctieBegin
PHARMACIELO LTD. Algemeen Directeur 10-07-2023
CRESCO LABS INC. Directeur/Bestuurslid 29-07-2020
AEQUUS PHARMACEUTICALS INC. Directeur/Bestuurslid 15-02-2021
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -

Eerdere bekende functies van Marc Lustig

BedrijvenFunctieEinde
BRIACELL THERAPEUTICS CORP. Directeur/Bestuurslid 23-11-2024
NAVASOTA RESOURCES INC Voorzitter 05-06-2024
WELLFIELD TECHNOLOGIES INC. Voorzitter 06-10-2023
░░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Marc Lustig in detail bekijken

Opleiding van Marc Lustig

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

23

Eerstegraads connecties

25

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit25

Health Technology

Process Industries

Finance

Finance

Process Industries

Health Technology

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Process Industries

Process Industries

Health Technology

Finance

Retail Trade

Process Industries

Finance

Process Industries

Process Industries

Cedars Cancer Foundation

Finance

Finance

Finance

  1. Beurs
  2. Insiders
  3. Marc Lustig
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU